why choose us

First received: August 29, 2022

Clinical Trial: Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pancreatic Cancer

Study Type: INTERVENTIONAL


Official Title: Intravenous Lidocaine for Pain Associated With Pancreatic Cancer and Chronic Pancreatitis (LIDOPAN)

Brief Summary: Pain is a major clinical problem for many patients with pancreatic cancer and chronic pancreatitis (CP).In pancreatic cancer, nearly 75% of patients suffer from pain at the time of diagnosis, with over 90% of patients in advanced stages.In CP, pain occurs in 80-90% of patients and strongly affects quality of life.For both conditions, the majority of pain is addressed using the WHO analgesic ladder.However, more invasive pain therapies are often necessary.Currently, in several centers in the Netherlands, treatment…

Read more